These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25201428)

  • 1. A case of iatrogenic Cushing syndrome and apparent mineralocorticoid excess presenting with accelerated hypertension and proteinuria.
    Kong WY; Leedman P; Irish A
    Intern Med J; 2014 Sep; 44(9):932-4. PubMed ID: 25201428
    [No Abstract]   [Full Text] [Related]  

  • 2. Medroxyprogesterone acetate induced Cushing's syndrome.
    Shotliff K; Nussey SS
    Br J Clin Pharmacol; 1997 Sep; 44(3):304. PubMed ID: 9296330
    [No Abstract]   [Full Text] [Related]  

  • 3. Cushing's syndrome with adrenal suppression and masked hyperandrogenism by high-dose medroxyprogesterone acetate for treatment of endometrial cancer in a young woman with polycystic ovarian syndrome.
    Seo Y; Jeong EG; Kim ES
    Endocrine; 2015 Nov; 50(2):519-21. PubMed ID: 26298265
    [No Abstract]   [Full Text] [Related]  

  • 4. Cushing's syndrome and hypothalamic-pituitary adrenal axis suppression induced by medroxyprogesterone acetate.
    Malik KJ; Wakelin K; Dean S; Cove DH; Wood PJ
    Ann Clin Biochem; 1996 May; 33 ( Pt 3)():187-9. PubMed ID: 8791979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestogens and Cushing's syndrome.
    Harte C; Henry MT; Murphy KD; Mitchell TH
    Ir J Med Sci; 1995; 164(4):274-5. PubMed ID: 8522428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conservative hormonal therapy for endometrial cancer].
    Susumu N; Aoki D; Tamada Y; Banno K; Suzuki A; Suzuki N; Nozawa S
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():375-80. PubMed ID: 15535271
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medroxyprogesterone acetate for treatment of advanced breast cancers].
    Mitsuyama S; Anan K
    Nihon Rinsho; 2000 Apr; 58 Suppl():317-21. PubMed ID: 11026012
    [No Abstract]   [Full Text] [Related]  

  • 8. The dangers of herbal teas: hypertension and weakness caused by liquorice-induced apparent mineralocorticoid excess.
    Pandher R; Puvanendran A; Diamond TH
    Med J Aust; 2020 Sep; 213(5):207-208.e1. PubMed ID: 32776334
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of medications and hormones used in pediatric endocrinology: adrenal.
    Frank GR; Speiser PW; Griffin KJ; Stratakis CA
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():134-45. PubMed ID: 16456492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cushing syndrome and medroxyprogesterone acetate.
    Donckier JE; Michel LA; Buysschaert M
    Lancet; 1990 May; 335(8697):1094. PubMed ID: 1970386
    [No Abstract]   [Full Text] [Related]  

  • 11. Posaconazole-Induced Pseudohyperaldosteronism.
    Kuriakose K; Nesbitt WJ; Greene M; Harris B
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription of medroxyprogesterone acetate to a patient with pedophilia, resulting in Cushing's syndrome and adrenal insufficiency.
    Krueger RB; Hembree W; Hill M
    Sex Abuse; 2006 Apr; 18(2):227-8. PubMed ID: 16868842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
    Al-Harbi T; Al-Shaikh A
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1083-8. PubMed ID: 23329753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cushing's syndrome and medroxyprogesterone acetate.
    Grenfell A; Rudenski A; Watts M; Wiltshire C; Day JL; Gray IP
    Lancet; 1990 Jul; 336(8709):256. PubMed ID: 1973810
    [No Abstract]   [Full Text] [Related]  

  • 15. Cushing's syndrome induced by medroxyprogesterone.
    Merrin PK; Alexander WD
    BMJ; 1990 Aug; 301(6747):345. PubMed ID: 2144198
    [No Abstract]   [Full Text] [Related]  

  • 16. Iatrogenic Cushing syndrome after intra-articular triamcinolone in a patient receiving ritonavir-boosted darunavir.
    Hall JJ; Hughes CA; Foisy MM; Houston S; Shafran S
    Int J STD AIDS; 2013 Sep; 24(9):748-52. PubMed ID: 23970582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cushing syndrome induced by medroxyprogesterone acetate.
    Siminoski K; Goss P; Drucker DJ
    Ann Intern Med; 1989 Nov; 111(9):758-60. PubMed ID: 2552887
    [No Abstract]   [Full Text] [Related]  

  • 18. [Iatrogenic Cushing syndrome in infants. Report of a case with dwarfism].
    Petrus M; Netter JC; Rance F; Chateauneuf R; Bildstein G; Cabalet C; Sermet J; Delprat A
    Ann Pediatr (Paris); 1990 Jan; 37(1):48-50. PubMed ID: 2316961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Iatrogenic Cushing's syndrome caused by an acute overdose of triamcinolone].
    Girre C; Vincens M; Gompel A; Fournier PE
    Therapie; 1987; 42(3):317-8. PubMed ID: 3660326
    [No Abstract]   [Full Text] [Related]  

  • 20. Apparent mineralocorticoid excess as a side effect of ketoconazole therapy in a patient with Cushing's disease.
    Luque-Ramírez M; Ortiz-Flóres AE; Nattero-Chávez L; Escobar-Morreale HF
    Clin Endocrinol (Oxf); 2020 Jan; 92(1):80-83. PubMed ID: 31667853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.